Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Imunon, Inc.IMNN · Entity 8041 | Chief Scientific Officer | January 02, 2026 | January 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Imunon, Inc.
Report date January 02, 2026 · Filed January 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.95 · Expires 2036-01-02 | Direct | 15,736 |
Reported balance
After 2026-01-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-02 · Grant · Acquired 15,736 · Balance 15,736 F1: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant F2: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant
F2: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2026 Filed Jan 6, 2026 21:09 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantStock Option (Right to Buy) · Derivative | 15,736 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001437749-26-000613 · rdgdoc.xml · derivative · entry 1 Anwer Khursheed · CIK 0001611756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,736 Underlying: Common Stock · 15,736 shares Expires 2036-01-02 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| August 04, 2025 Filed Aug 6, 2025 20:28 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantStock Option (Right to Buy) · Derivative | 1,667 | $0.00 Strike: $9.20 | $0.00 |
DisclosureSEC source: 0001437749-25-025091 · rdgdoc.xml · derivative · entry 1 Anwer Khursheed · CIK 0001611756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,667 Underlying: Common Stock · 1,667 shares Expires 2035-08-04 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 20:46 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantStock Option (Right to Buy) · Derivative | 40,653 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001437749-24-028872 · rdgdoc.xml · derivative · entry 1 Anwer Khursheed · CIK 0001611756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,486 Underlying: Common Stock · 40,653 shares Expires 2034-09-06 F2 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F3 · shares: Option granted in lieu of cash payment increases. F1 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 10:11 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001437749-24-020262 · rdgdoc.xml · derivative · entry 1 Anwer Khursheed · CIK 0001611756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,688 Underlying: Common Stock · 25,000 shares Expires 2034-06-12 F2 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F1 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 21:10 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001437749-24-008347 · rdgdoc.xml · derivative · entry 1 Anwer Khursheed · CIK 0001611756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,688 Underlying: Common Stock · 25,000 shares Expires 2034-03-15 F2 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F1 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| March 14, 2024 Filed Mar 18, 2025 20:23 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001437749-25-008269 · rdgdoc.xml · derivative · entry 1 Anwer Khursheed · CIK 0001611756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-03-14 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:38 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001437749-23-007403 · rdgdoc.xml · derivative · entry 1 Anwer Khursheed · CIK 0001611756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,688 Underlying: Common Stock · 40,000 shares Expires 2033-03-17 F2 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F1 · derivative.exercise_date: The options vest as follows: 1/3 on the date of grant; 1/3 on the on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. Read SEC document |
| May 15, 2018 Filed May 16, 2018 21:12 UTC | Imunon, Inc. CLSN · Entity 8041 | GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 100,000 | $0.00 Strike: $2.22 | $0.00 |
DisclosureSEC source: 0001437749-18-010167 · rdgdoc.xml · derivative · entry 1 Anwer Khursheed · CIK 0001611756 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,643 Underlying: Celsion Corporation Common Stock · 100,000 shares Expires 2028-05-15 F1 · derivative.exercise_price: Represents the closing stock price on the option grant date (February 12, 2018) which was subject to the approval of the Celsion Corporation 2018 Stock Incentive Plan at the Annual Meeting of Stockholders held on May 15, 2018. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 20:44 UTC | Imunon, Inc. CLSN · Entity 8041 | GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 21,786 | $0.00 Strike: $2.69 | $0.00 |
DisclosureSEC source: 0001437749-17-010477 · rdgdoc.xml · derivative · entry 1 Anwer Khursheed · CIK 0001611756 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,786 Underlying: Celsion Corporation Common Stock · 21,786 shares Expires 2027-05-30 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.